Last reviewed · How we verify
nitroglycerine
At a glance
| Generic name | nitroglycerine |
|---|---|
| Also known as | trinitroglycerin,trinitroglycerine,glyceryl trinitrate |
| Sponsor | University Hospital, Ghent |
| Target | Atrial natriuretic peptide receptor 1, Soluble guanylate cyclase |
| Modality | Small molecule |
| Therapeutic area | Metabolic |
| Phase | FDA-approved |
Approved indications
- Angina Pectoris Prevention
- Angina pectoris
- Left ventricular cardiac dysfunction
- Perioperative hypertension
Common side effects
Key clinical trials
- Glyceryl Trinitrate Gel Phonophoresis on Planter Fasciiatis (NA)
- Effect of Topically-applied Milrinone or Nitroglycerin on Internal Mammary Artery Free Flow (PHASE3)
- Subcutaneous Nitroglycerin to Facilitate Trans-radial Access. (PHASE4)
- Evaluating the Effects of Nitroglycerin on Heart Function and Urinary Output in Patients With Acute Heart Failure (PHASE4)
- Mannitol Versus Nitroglycerin for Kidney Injury Prevention in Robotic-assisted Radical Prostatectomy or Cystectomy (NA)
- Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule (NA)
- A Study to Learn About How Safe Nitroglycerin is and How it Affects the Body When Taken Along With Nurandociguat in People With Coronary Artery Disease (PHASE1)
- Optimized Strict Fluid Management Helps Improve Endpoints After Liver Dissection (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- nitroglycerine CI brief — competitive landscape report
- nitroglycerine updates RSS · CI watch RSS
- University Hospital, Ghent portfolio CI